Patent details

Basic Information

Publication number:

EP1993557

PCT Application Number:

PCT/US/2007/002948

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP077631885

PCT Publication Number:

WO/2007/092343

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL EPOPROSTENOL FORMULATION AND METHOD OF MAKING THEREOF

French Title of Invention:

NOUVELLE FORMULATION D'EPOPROSTENOL ET SON PROCEDE DE FABRICATION

German Title of Invention:

NEUARTIGE EPOPROSTENOLFORMULIERUNG UND HERSTELLUNGSVERFAHREN DAFÜR

SPC Number:

Dates

Filing date:

02/02/2007

Grant date:

11/11/2015

EP Publication Date:

11/11/2015

PCT Publication Date:

16/08/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/11/2008

EP B1 Publication Date:

11/11/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

02/02/2027

Renunciation date:

Revocation date:

02/02/2021

Annulment date:

Owner

From:

02/02/2007

 

 

Name:

Actelion Pharmaceuticals Ltd.

Address:

Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

18/11/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

PALEPU Nagesh R.

Address:

United States (US)

Priority

1

Priority Number:

764769 P

Priority Date:

03/02/2006

Priority Country:

United States (US)

2

Priority Number:

772563 P

Priority Date:

13/02/2006

Priority Country:

United States (US)

3

Priority Number:

783429 P

Priority Date:

20/03/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/557;

Publication

Bulletin

Bulletin Heading:

VRV

Bulletin edition number:

2021/08

Publication date:

01/07/2021

Description:

Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:

202126

Publication date:

30/06/2021

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

25/01/2021

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages